Abstract
This first detailed report of a female patient with functional methionine synthase deficiency due to the cblE defect describes treatment with several vitamins and cofactors and clinical progress for 17 years. Before treatment, Major findings were microcephaly, psychomotor retardation, episodic reduced consciousness, megaloblastic anaemia, increased plasma free homocystine (>20 mu mol/L), low glutamate. plasma methionine (
In cultured fibroblasts methionine synthesis was reduced (0.03 nmol/mg/per 16 h, controls 2.4-6.9); methionine synthase activity was normal under high reducing conditions but decreased on limiting the reducing agent, dithiothreitol, to 5 mmol/L (18% of total, controls 51-51%); formation of methylcobalamin was low (4.5% of total cobalamins, control 57.5%) and complementation studies indicated the cblE defect. Methionine formation showed only minor increases in cells grown in folate-or cobalamin-supplemented medium. Serine synthesis, which was low in normal medium, increased with cobalamin supplementation. These studies suggest further heterogeneity within cblE mutants, show the difficulty of establishing the enzyme defect in vitro, and indicate a role for folate in addition to cobalamin in treatment.
Original language | English |
---|---|
Pages (from-to) | 731-741 |
Number of pages | 11 |
Journal | Journal of Inherited Metabolic Disease |
Volume | 20 |
Issue number | 6 |
Publication status | Published - Nov-1997 |
Keywords
- METHYLCOBALAMIN DEFICIENCY
- COBALAMIN METABOLISM
- VITAMIN-B12 THERAPY
- HUMAN FIBROBLASTS
- INBORN-ERRORS
- ANEMIA
- HETEROGENEITY
- DEFECT
- SYNTHETASE
- CONVERSION